Oral Microbiota and Immune System Crosstalk: A Translational Research
- PMID: 32560235
- PMCID: PMC7344575
- DOI: 10.3390/biology9060131
Oral Microbiota and Immune System Crosstalk: A Translational Research
Abstract
Background: Oral pathogens may exert the ability to trigger differently the activation of local macrophage immune responses, for instance Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans induce predominantly pro-inflammatory (M1-like phenotypes) responses, while oral commensal microbiota primarily elicits macrophage functions consistent with the anti-inflammatory (M2-like phenotypes).
Methods: In healthy individuals vs. periodontal disease patients' blood samples, the differentiation process from monocyte to M1 and M2 was conducted using two typical growth factors, the granulocyte/macrophage colony stimulating factor (GM-CSF) and the macrophage colony stimulating factor (M-CSF).
Results: In contrast with the current literature our outcomes showed a noticeable increase of macrophage polarization from healthy individuals vs. periodontal patients. The biological and clinical significance of these data was discussed.
Conclusions: Our translational findings showed a significant variance between control versus periodontal disease groups in M1 and M2 marker expression within the second group significantly lower skews differentiation of M2-like macrophages towards an M1-like phenotype. Macrophage polarization in periodontal tissue may be responsible for the development and progression of inflammation-induced periodontal tissue damage, including alveolar bone loss, and modulating macrophage function may be a potential strategy for periodontal disease management.
Keywords: clinical biochemistry; clinical microbiology; immune system; lymphocytes; macrophage polarization; microbiota; oral pathology; oral-systemic disease; periodontal disease; translational research.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Ballini A., Santacroce L., Cantore S., Bottalico L., Dipalma G., Topi S., Saini R., De Vito D., Inchingolo F. Probiotics efficacy on oxidative stress values in inflammatory bowel disease: A randomized double-blinded placebo-controlled pilot study. Endocr. Metab. Immune. Disord. Drug Targets. 2019;19:373–381. doi: 10.2174/1871530319666181221150352. - DOI - PubMed
-
- Inchingolo F., Martelli F.S., Gargiulo Isacco C., Borsani E., Cantore S., Corcioli F., Boddi A., Nguyễn K.C.D., De Vito D., Aityan S.K., et al. Chronic Periodontitis and Immunity, Towards the Implementation of a Personalized Medicine: A Translational Research on Gene Single Nucleotide Polymorphisms (SNPs) Linked to Chronic Oral Dysbiosis in 96 Caucasian Patients. Biomedicines. 2020;8:115. doi: 10.3390/biomedicines8050115. - DOI - PMC - PubMed
-
- Mori G., Brunetti G., Colucci S., Oranger A., Ciccolella F., Sardone F., Pignataro P., Mori C., Karapanou V., Ballini A., et al. Osteoblast apoptosis in periodontal disease: Role of TNF-related apoptosis-inducing ligand. Int. J. Immunopathol. Pharmacol. 2009;22:95–103. doi: 10.1177/039463200902200111. - DOI - PubMed
-
- Caton J.G., Armitage G., Berglundh T., Chapple I.L.C., Jepsen S., Kornman K.S., Mealey B.L., Papapanou P.N., Sanz M., Tonetti M.S. A new classification scheme for periodontal and peri-implant diseases and conditions-Introduction and key changes from the 1999 classification. J. Clin. Periodontol. 2018;89:S1–S8. doi: 10.1002/JPER.18-0157. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
